Table 3.

Results of phenotypic and molecular detection of resistance in strains of E. coli causing UTIs

Strain Code	Antibiogram Patterns	MIC (μg/ml)		Phenotypic		Genotypic		Other Resistance genes		ORDR
		CIP	GEN	ESBLs	AmpC	pAmpC	ESBLs	PMQRs	AGS	ParC	GyrA
P1	NA, NOR, CIP, GEN,	32	512	NEG	NEG	Negative	blaSHV, blaTEM, blaCTX-M-15	Negative	aacC2	ND	ND
P2	NA, NOR, CIP, GEN, COT	32	256	NEG	NEG	Negative	blaTEM	Negative	aacC2	ND	ND
P3	CFT, CFP, NA, NOR, CIP, GEN, COT	256	256	POS	NEG	Negative	blaSHV, blaTEM, blaCTX-M-15	Negative	aacC2	POS	POS
P6	NA, COT	0.25	0.5	NEG	NEG	Negative	BlaTEM, blaCTX-M-15	Negative	ND	POS	POS
P7	Fully susceptible	0.125	0.5	NEG	NEG	blaCMY-2	blaTEM, blaCTX-M-15	Negative	aadA2, aacC2	POS	POS
P8	NA, NOR, CIP,	256	1	NEG	NEG	blaCMY-2	blaTEM	Negative	ND	ND	ND
P9	TZP, NA, NOR, CIP, COT	512	2	NEG	NEG	blaCMY-2	blaOXA-1, blaTEM blaCTX-M-15	qnrD, aac(6′)-Ib	ND	POS	POS
P10	COT	0.125	1	NEG	NEG	blaCMY-2		Negative	aadA2	ND	ND
P11	CFT, CFP, NA, NOR, CIP, GEN, COT	512	32	POS	NEG	Negative	blaOXA-1, blaTEM blaCTX-M-15	qnrD, aac(6′)-Ib	aacC2, aac(3)-IV	POS	POS
P12	CFT, CFP, COT	1	1	POS	NEG	Negative	blaSHV, blaTEM, blaCTX-M-15	Negative	ND	ND	ND
P13	CFP, NA, COT	1	2	NEG	NEG	Negative	blaSHV, blaTEM	Negative	ND	POS	POS
P14	COT	0.125	1	POS	NEG	blaCMY-2	blaCTX-M-15	Negative	ND	ND	ND
P15	COT	0.125	2	NEG	NEG	Negative	blaTEM	Negative	ND	ND	ND
P16	NA, NOR, CIP	32	1	NEG	NEG	Negative	NEG	Negative	Negative	ND	ND
P19	CFT, CFP, TZP, NA, NOR, CIP, COT	512	4	NEG	NEG	Negative	blaOXA-1, blaTEM	qnrD, qnrS	ND	ND	ND
P20	Fully susceptible	1	1	NEG	NEG	Negative	blaTEM and blaCTX-M-15	Negative	ND	POS	POS
P21A	NA, NOR, CIP, GEN, COT	256	256	POS	NEG	Negative	blaSHV, blaTEM, blaCTX-M-15	qnrD, qnrS	aadA2, aacC2	ND	ND
P21B	NA, NOR, CIP, GEN, COT	256	128	NEG	NEG	Negative	blaTEM	qnrD, qnrS	aadA2, aacC2	ND	ND
P22	COT	0.125	1	NEG	NEG	blaCMY-2	blaTEM, blaCTX-M-15	Negative	ND	ND	ND
P23	NA, NOR, CIP, GEN, COT	256	64	NEG	NEG	blaCMY-2	blaTEM	Negative	aacC2	ND	ND
P24	NA, NOR, CIP, GEN, COT	256	128	NEG	NEG	Negative	blaTEM, blaCTX-M-15	Negative	aadA1, aadA2, aacC2	ND	ND
P25	NA, NOR, CIP, GEN, COT	256	128	NEG	NEG	Negative	blaSHV, blaTEM and blaCTX-M-15	qnrS	aadA1, aadA2, aacC2	ND	ND
P26	CFT, CFP, NA, NOR, CIP, GEN, COT	256	256	POS	NEG	blaCMY-2	blaOXA-1, blaSHV, blaTEM and blaCTX-M-15	qnrB, aac(6′)-Ib	aadA1, aadA2, aacC2	POS	POS
P28	NA, NOR, CIP, GEN, COT	256	128	NEG	NEG	Negative	blaOXA-1, blaTEM, blaCTX-M-15	Negative	aadA1, aadA2, aacC2	ND	ND
P29	Fully susceptible	1	2	NEG	NEG	Negative	blaTEM, blaCTX-M-15	Negative	aacC2	ND	ND

CFT, cefotaxime; CFP, cepoferazone; TZP, taxobactam/piperacillin; NA, nalidix acid; NOR, norfloxacin; CIP, ciprofloxacin; GEN, gentamicin; COT, co-trimoxazole; ND; not determined; AGS, aminoglycosides; POS, positive; NEG, negative